BPC-157 is studied for a potential role in reducing inflammation and supporting tissue protection, particularly in the digestive system
Instead of beginning with Which peptide should I take? the process begins with the patients symptoms, goals, medical history, medications, nutrition, recovery patterns, prior injuries, and risk factors
Peptides like CJC-1295 + Ipamorelin are preferred for those avoiding suppression
Academic institutions, independent research organizations, or collaborative pharmaceutical initiatives could theoretically pursue these questions, though competitive dynamics make such studies unlikely in the near term
Combining hormone therapies raises the need for regular lab monitoring, which is why a clinician should oversee the protocol rather than a do-it-yourself routine
2004 Jul;11 Suppl 1:S73-85